Clinical Trials Logo
  1. Home
  2. Prenatal Disorder
  3. NCT03715036

Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits

Prenatal Disorder Clinical Trial

Official title:
Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits: a Randomized Controlled Trial. MUNN (More Ultrasounds New gaiNs) Trial

Clinical Trial Summary

Abdominal circumference (AC) in the fetus is the single most useful indicator of fetal growth abnormalities. Measurement of AC as well as DVP do not require extensive training. Our objective is to evaluate if introduction of bedside ultrasound during routine antenatal visits to evaluate fetal AC and amniotic fluid DVP would decrease the false positive rates of fundal height measurement in diagnosing intrauterine growth abnormalities.

Clinical Trial Description

The prior studies of routine ultrasound in low risk patients focused on the usual ultrasound evaluation which involves the use of advanced equipment and providers, including trained sonographers and physicians to perform and review the ultrasound, as well as a full examination with multiple fetal measurements and images. A number of recent analyses show that measurement of the abdominal circumference (AC) in the fetus is the single most useful indicator of fetal growth abnormalities. Measurement of AC as well as DVP do not require extensive training, long time to acquire, or expensive ultrasound machines. They can be easily performed in the office by providers who are specifically trained in obtaining these 2 measurements. Therefore, we intended to evaluate if introduction of bedside ultrasound during routine antenatal visits (point of care ultrasound or POC-US) to evaluate fetal AC and amniotic fluid DVP would decrease the false positive rates of fundal height measurement in diagnosing intrauterine growth abnormalities, and would improve the diagnosis of amniotic fluid volume and fetal growth deviations. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03715036
Study type Interventional
Source The University of Texas Medical Branch, Galveston
Contact
Status Completed
Phase N/A
Start date April 29, 2019
Completion date March 30, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04364646 - Personalized Integrated Chronotherapy for Perinatal Depression N/A
Completed NCT03441672 - Game-Based Decision Aid to Educate Pregnant Women About Prenatal Screening N/A
Not yet recruiting NCT06382636 - Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes N/A
Recruiting NCT05360095 - Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education N/A
Recruiting NCT03680651 - Frequency and Type of Genetic Abnormalities Found in Antenatal Corpus Callosum Malformation
Not yet recruiting NCT04729361 - CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction
Not yet recruiting NCT04737083 - CGH Array in Bilateral Clubfoot
Active, not recruiting NCT03831256 - PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood N/A
Completed NCT03420274 - Ensuring Patients' Informed Access to Noninvasive Prenatal Testing N/A
Recruiting NCT04595214 - Develop a Multi-disciplinary Approach for a Personalized Prenatal Diagnostics and Care for Twin Pregnancies
Completed NCT03898440 - Fetal Ano-genital Distance in 2D Ultrasound.